FWIA
GHDX

Fort Washington Investment Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Fort Washington Investment Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-108,953
Closed -$3.19M – 508
2013
Q4 		$3.19M Sell
108,953
-26,690
-20% -$847K 0.07% 184
2013
Q3 		$4.15M Sell
135,643
-158,612
-54% -$5.3M 0.1% 150
2013
Q2 		$9.33M Buy
+294,255
New +$9.66M 0.21% 103

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Fort Washington Investment Advisors's GHDX Position: Q1 2014 in Review

Fort Washington Investment Advisors sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 108,953 shares — an estimated $3.19M sold.

Fort Washington Investment Advisors first reported a position in GHDX in Q2 2013 and held it in 3 quarters. The position peaked at $9.33M in Q2 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Fort Washington Investment Advisors reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 108,953 Genomic Health, Inc. shares in Q1 2014, an estimated $3.19M.
  • Fort Washington Investment Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 3 quarters.
  • Fort Washington Investment Advisors's Genomic Health, Inc. position peaked at $9.33M in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Fort Washington Investment Advisors's 13F filing for Q1 2014, filed 13 May 2014.